![Documents Document Submission](/images/default-source/default-album/document-review/documents.jpg?sfvrsn=d9b80dc1_1)
Rate This Document
FDA Perspective on Approaches for Complying with CGMPS During Phase I INDs Draft Guidance for Industry
- Description: by Laurie P. Norwood, M.S., Chief/MRBII/DMPQ/OCBQ, Center for Biologics Evaluation and Research
- Published on: Nov 15, 2023
- Rating Period:
Your rating for this document has already been submitted